Amie Hiller
Overview
Explore the profile of Amie Hiller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jiao J, Brumbach B, Lobb B, Goldhirsch S, Hiller A
J Palliat Med
. 2024 Jun;
27(8):984-985.
PMID: 38916068
No abstract available.
2.
Denne T, Winfrey L, Moore C, Whitner C, DSilva T, Soumyanath A, et al.
Mol Cell Neurosci
. 2023 Aug;
126:103883.
PMID: 37527694
There is growing interest in the use of natural products for the treatment of Parkinson's disease (PD). Mucuna pruriens has been used in the treatment of humans with PD. The...
3.
Morris R, Martini D, Kelly V, Smulders K, Ramsey K, Hiller A, et al.
Clin Park Relat Disord
. 2023 May;
9:100201.
PMID: 37252677
Background: Gait and balance impairments are among the most troublesome and heterogeneous in Parkinson's disease (PD). This heterogeneity may, in part, reflect genetic variation. The apolipoprotein E () gene has...
4.
Feeney M, Duda J, Hiller A, Phillips J, Evers C, Yarab N, et al.
Front Neurol
. 2022 Aug;
13:924999.
PMID: 36034294
Among Veterans, it is estimated that 110,000 are living with Parkinson's disease (PD) in the United States. Whether or not Veterans living with PD are enrolled in the Veterans Health...
5.
Lim M, Sarva H, Hiller A, Feitell S, Oates P, Barone D, et al.
Parkinsonism Relat Disord
. 2022 Aug;
102:86-88.
PMID: 35977449
No abstract available.
6.
Morris R, Martini D, Ramsey K, Kelly V, Smulders K, Hiller A, et al.
NPJ Parkinsons Dis
. 2022 Jun;
8(1):78.
PMID: 35725575
The extent to which the heterogeneity of gait and balance problems in PD may be explained by genetic variation is unknown. Variants in the glucocerebrosidase (GBA) gene are the strongest...
7.
Neilson L, Hollen C, Hiller A, Wooliscroft L
Front Neurosci
. 2022 Mar;
16:852939.
PMID: 35295090
Multiple System Atrophy (MSA) is a neurodegenerative disease with heterogeneous manifestations and is therefore difficult to diagnose definitively. Because of this, oftentimes an extensive workup for mimickers is undertaken. We...
8.
Smolders J, Hiller A, Camu W
Front Neurol
. 2021 Mar;
12:614900.
PMID: 33767657
No abstract available.
9.
Martini D, Morris R, Madhyastha T, Grabowski T, Oakley J, Hu S, et al.
J Gerontol A Biol Sci Med Sci
. 2020 Nov;
76(4):630-637.
PMID: 33252618
Background: Reduced cortical sensorimotor inhibition is associated with mobility and cognitive impairments in people with Parkinson's disease (PD) and older adults (OAs). However, there is a lack of clarity regarding...
10.
Martini D, Morris R, Kelly V, Hiller A, Chung K, Hu S, et al.
Front Neurol
. 2020 Oct;
11:893.
PMID: 33013627
Mobility and sensorimotor inhibition impairments are heterogeneous in Parkinson's disease (PD). Genetics may contribute to this heterogeneity since the apolipoprotein () ε4 allele and glucocerebrosidase () gene variants have been...